Ricardo Pérez-Tomás Selected Research

Alkaloids

6/2005

DNA interaction and dual topoisomerase I and II inhibition properties of the anti-tumor drug prodigiosin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ricardo Pérez-Tomás Research Topics

Disease

27	Neoplasms (Cancer) 10/2023 - 02/2003
7	Lung Neoplasms (Lung Cancer) 01/2019 - 12/2003
6	Neoplasm Metastasis (Metastasis) 10/2023 - 01/2016
4	Melanoma (Melanoma, Malignant) 12/2022 - 01/2013
3	Carcinogenesis 11/2020 - 01/2010
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2011 - 12/2003
3	Breast Neoplasms (Breast Cancer) 02/2007 - 12/2005
2	Ameloblastoma 02/2023 - 10/2021
2	Odontogenic Cysts (Keratocyst) 02/2023 - 10/2021
2	Necrosis 07/2022 - 04/2013
2	Inflammation (Inflammations) 10/2021 - 01/2021
1	Cysts 02/2023
1	Acidosis 11/2020
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Hypoxia (Hypoxemia) 01/2016
1	Adenocarcinoma 01/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Neuroblastoma 10/2007
1	Colonic Neoplasms (Colon Cancer) 11/2005
1	Carcinoma (Carcinomatosis) 04/2005

Drug/Important Bio-Agent (IBA)

10	ProdigiosinIBA 12/2022 - 02/2003
9	Proteins (Proteins, Gene)FDA Link 02/2023 - 04/2005
4	AnionsIBA 01/2020 - 09/2011
4	Antineoplastic Agents (Antineoplastics)IBA 02/2017 - 12/2005
3	obatoclaxIBA 12/2022 - 01/2013
3	indoleIBA 01/2017 - 12/2013
2	Lactic Acid (Lactate)FDA LinkGeneric 10/2023 - 11/2020
2	Caspase 3 (Caspase-3)IBA 07/2022 - 04/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2021 - 01/2021
2	LigandsIBA 05/2021 - 01/2019
2	EnzymesIBA 01/2021 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 06/2005
2	multidrug resistance-associated protein 1IBA 01/2014 - 04/2005
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 02/2023
1	Cisplatin (Platino)FDA LinkGeneric 07/2022
1	Chloroquine (Aralen)FDA LinkGeneric 07/2022
1	3-methyladenineIBA 07/2022
1	Cyclin D1IBA 10/2021
1	OMS 2017IBA 10/2021
1	CytokinesIBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 11/2020
1	SurvivinIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Caffeine (No Doz)FDA LinkGeneric 01/2019
1	Histones (Histone)IBA 01/2018
1	Therapeutic UsesIBA 01/2017
1	p38 Mitogen-Activated Protein KinasesIBA 01/2017
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2016
1	ProteomeIBA 01/2016
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2014
1	LipidsIBA 01/2014
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2014
1	prodiginineIBA 12/2013
1	Caspase 8 (Caspase-8)IBA 04/2013
1	Dacarbazine (DIC)FDA LinkGeneric 04/2013
1	Caspase 9IBA 04/2013
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2013
1	CurcuminIBA 04/2013
1	IonophoresIBA 12/2011
1	Cytotoxins (Cytolysins)IBA 05/2009
1	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2007
1	Glycogen Synthase (Synthase I)IBA 01/2007
1	Complementary DNA (cDNA)IBA 01/2007
1	DepsipeptidesIBA 12/2005
1	serratamolideIBA 12/2005
1	hydrogen-chloride symporterIBA 11/2005
1	AlkaloidsIBA 06/2005
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 06/2005
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 06/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2005
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 12/2003
1	undecylprodigiosinIBA 02/2003
1	cycloprodigiosinIBA 02/2003

Therapy/Procedure

5	Therapeutics 10/2019 - 05/2009
3	Drug Therapy (Chemotherapy) 04/2013 - 01/2006
1	Aftercare (After-Treatment) 04/2013
1	Radiotherapy 05/2009